These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9613123

  • 1. [Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer].
    Katayama S, Shiota G, Kawasaki H.
    Nihon Rinsho; 1998 May; 56(5):1204-8. PubMed ID: 9613123
    [Abstract] [Full Text] [Related]

  • 2. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M, Albanell J, Drullinsky P, Han W, Guillem J, Scher HI, Reuter V, Moore MA.
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [Abstract] [Full Text] [Related]

  • 3. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M, Drullinsky P, Guillem J, Moore MA.
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [Abstract] [Full Text] [Related]

  • 4. Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
    Abe N, Watanabe T, Nakashima M, Masaki T, Mori T, Sugiyama M, Atomi Y.
    Hepatogastroenterology; 2001 Nov; 48(39):692-5. PubMed ID: 11462905
    [Abstract] [Full Text] [Related]

  • 5. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
    Takagi S, Kinouchi Y, Hiwatashi N, Chida M, Nagashima F, Takahashi S, Negoro K, Shimosegawa T, Toyota T.
    Cancer; 1999 Oct 15; 86(8):1431-6. PubMed ID: 10526269
    [Abstract] [Full Text] [Related]

  • 6. [Detection of telomerase activity in intestinal lavage solution from colorectal carcinoma patients].
    Ishibashi K, Wakasugi S, Ogawa K, Kato H, Endo S, Yoshimatsu K, Haga S, Hirose K, Kajiwara T.
    Nihon Rinsho; 1998 May 15; 56(5):1209-13. PubMed ID: 9613124
    [Abstract] [Full Text] [Related]

  • 7. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R, Rosenberg R, Stricker D, Friederichs J, Hoos A, Werner M, Ulm K, Holzmann B, Nekarda H, Siewert JR.
    J Clin Oncol; 2004 May 15; 22(10):1807-14. PubMed ID: 15143073
    [Abstract] [Full Text] [Related]

  • 8. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
    Patel MM, Parekh LJ, Jha FP, Sainger RN, Patel JB, Patel DD, Shah PM, Patel PS.
    Head Neck; 2002 Dec 15; 24(12):1060-7. PubMed ID: 12454944
    [Abstract] [Full Text] [Related]

  • 9. Clinical usefulness of telomerase activity and telomere length in the preoperative diagnosis of gastric and colorectal cancer.
    Katayama S, Shiota G, Oshimura M, Kawasaki H.
    J Cancer Res Clin Oncol; 1999 Jul 15; 125(7):405-10. PubMed ID: 10394961
    [Abstract] [Full Text] [Related]

  • 10. Determination of telomerase activity and telomere length.
    Wu KD, Moore MA.
    Methods Mol Med; 2005 Jul 15; 113():207-23. PubMed ID: 15968105
    [Abstract] [Full Text] [Related]

  • 11. [Telomerase activity and telomere length as diagnostic tumor marker for ovarian tumors].
    Murakami J, Nagai N, Ohama K.
    Nihon Rinsho; 1998 May 15; 56(5):1310-5. PubMed ID: 9613143
    [Abstract] [Full Text] [Related]

  • 12. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C, de Juan C, Diaz-Lopez A, Sanchez-Pernaute A, Torres AJ, Diaz-Rubio E, Balibrea JL, Benito M, Iniesta P.
    Cancer; 2006 Feb 01; 106(3):541-51. PubMed ID: 16388518
    [Abstract] [Full Text] [Related]

  • 13. [Telomere length and telomerase activity in hepatocellular carcinoma].
    Nakashio R, Kitamoto M, Nakanishi T, Takaishi H, Takahashi S, Kajiyama G.
    Nihon Rinsho; 1998 May 01; 56(5):1239-43. PubMed ID: 9613130
    [Abstract] [Full Text] [Related]

  • 14. Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length.
    Kojima H, Miyazaki H, Shiwa M, Tanaka Y, Moriyama H.
    Laryngoscope; 2001 May 01; 111(5):867-73. PubMed ID: 11359168
    [Abstract] [Full Text] [Related]

  • 15. [Methods of measuring telomere length and telomerase activity--practice and problems].
    Saito Y, Suda T, Hatakeyama K.
    Nihon Rinsho; 1998 May 01; 56(5):1153-8. PubMed ID: 9613113
    [Abstract] [Full Text] [Related]

  • 16. [Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach].
    Maruyama Y, Hanai H, Kaneko E.
    Nihon Rinsho; 1998 May 01; 56(5):1186-9. PubMed ID: 9613119
    [Abstract] [Full Text] [Related]

  • 17. Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological features.
    Izgi A, Gunal A, Yalcin S, Gunduz U.
    Biomed Pharmacother; 2014 Sep 01; 68(7):841-6. PubMed ID: 25194444
    [Abstract] [Full Text] [Related]

  • 18. The relationship between telomere length and telomerase activity in gynecologic cancers.
    Wang SJ, Sakamoto T, Yasuda Si S, Fukasawa I, Ota Y, Hayashi M, Okura T, Zheng JH, Inaba N.
    Gynecol Oncol; 2002 Jan 01; 84(1):81-4. PubMed ID: 11748981
    [Abstract] [Full Text] [Related]

  • 19. Telomerase activity in ovarian tumors.
    Murakami J, Nagai N, Ohama K, Tahara H, Ide T.
    Cancer; 1997 Sep 15; 80(6):1085-92. PubMed ID: 9305709
    [Abstract] [Full Text] [Related]

  • 20. Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients.
    Sotillo-Piñeiro E, Sierrasesúmaga L, Patiñno-García A.
    Pediatr Res; 2004 Feb 15; 55(2):231-5. PubMed ID: 14630995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.